Literature DB >> 17823817

A shared antigen among Babesia species: ribosomal phosphoprotein P0 as a universal babesial vaccine candidate.

M Alaa Terkawi1, Honglin Jia, Aboge Gabriel, Youn-Kyoung Goo, Yoshifumi Nishikawa, Naoaki Yokoyama, Ikuo Igarashi, Kozo Fujisaki, Xuenan Xuan.   

Abstract

Babesia gibsoni ribosomal phosphoprotein P0 (BgP0) was previously identified as a cross-protective antigen against Babesia microti infection in mice. Interestingly, the same protein showed considerable antigenicity when tested with serum samples collected from Babesia-infected animals. Moreover, the polyclonal antibody raised against the recombinant BgP0 (rBgP0) recognized the P0 homologues from other Babesia species either by immunoblotting or by immunoscreening. The P0 genes from Babesia caballi, Babesia equi, and Babesia bigemina were then cloned and sequenced. The phylogenic analyses based on the amino acid sequences indicated that BgP0 has high identities with B. caballi P0 (88.1%), B. bigemina P0 (85.6%), Babesia bovis P0 (81.4%), and B. equi P0 (64.9%). Western blot analyses revealed that the corresponding native proteins ranged between 31 and 34 kDa, consistent with predicated molecular weight of Babesia P0. Furthermore, the immunogenic property of anti-rBgP0 IgG was evaluated against a B. bovis in vitro culture. The growth of B. bovis parasites was restricted by anti-rBgP0 IgG in a concentration-dependent manner, and significant reductions in parasitemia were observed only at 1 mg/ml in the culture. Taken together, these data suggest that P0 is a conserved protective antigen among Babesia species and might be a potentially universal vaccine candidate for babesiosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17823817     DOI: 10.1007/s00436-007-0718-1

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  28 in total

Review 1.  Designing blood-stage vaccines against Babesia bovis and B. bigemina.

Authors:  W C Brown; G H Palmer
Journal:  Parasitol Today       Date:  1999-07

2.  Cellular localization of Babesia bovis merozoite rhoptry-associated protein 1 and its erythrocyte-binding activity.

Authors:  Naoaki Yokoyama; Boonchit Suthisak; Haruyuki Hirata; Tomohide Matsuo; Noboru Inoue; Chihiro Sugimoto; Ikuo Igarashi
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

3.  Improved in vitro cultivation of Babesia caballi.

Authors:  A Avarzed; I Igarashi; T Kanemaru; K Hirumi; Y Omata; A Saito; T Oyamada; H Nagasawa; Y Toyoda; N Suzuki
Journal:  J Vet Med Sci       Date:  1997-06       Impact factor: 1.267

4.  The ves multigene family of B. bovis encodes components of rapid antigenic variation at the infected erythrocyte surface.

Authors:  D R Allred; J M Carlton; R L Satcher; J A Long; W C Brown; P E Patterson; R M O'Connor; S E Stroup
Journal:  Mol Cell       Date:  2000-01       Impact factor: 17.970

5.  Antibodies against ribosomal phosphoprotein P0 of Plasmodium falciparum protect mice against challenge with Plasmodium yoelii.

Authors:  S Chatterjee; S Singh; R Sohoni; N J Singh; A Vaidya; C Long; S Sharma
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 6.  Babesiosis.

Authors:  M J Homer; I Aguilar-Delfin; S R Telford; P J Krause; D H Persing
Journal:  Clin Microbiol Rev       Date:  2000-07       Impact factor: 26.132

Review 7.  Prospects for recombinant vaccines against Babesia bovis and related parasites.

Authors:  W C Brown; J Norimine; W L Goff; C E Suarez; T F McElwain
Journal:  Parasite Immunol       Date:  2006-07       Impact factor: 2.280

8.  Ribosomal protein P0, contrary to phosphoproteins P1 and P2, is required for ribosome activity and Saccharomyces cerevisiae viability.

Authors:  C Santos; J P Ballesta
Journal:  J Biol Chem       Date:  1994-06-03       Impact factor: 5.157

Review 9.  Canine babesiosis.

Authors:  A Lindsay Boozer; Douglass K Macintire
Journal:  Vet Clin North Am Small Anim Pract       Date:  2003-07       Impact factor: 2.093

10.  Growth-inhibitory effect of heparin on Babesia parasites.

Authors:  Sabine Bork; Naoaki Yokoyama; Yuzuru Ikehara; Sanjay Kumar; Chihiro Sugimoto; Ikuo Igarashi
Journal:  Antimicrob Agents Chemother       Date:  2004-01       Impact factor: 5.191

View more
  5 in total

1.  Identification and expression of Babesia ovis secreted antigen 1 and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.

Authors:  Ferda Sevinc; Shinuo Cao; Xuenan Xuan; Mutlu Sevinc; Onur Ceylan
Journal:  J Clin Microbiol       Date:  2015-02-18       Impact factor: 5.948

2.  Cloning and characterization of the acidic ribosomal protein P2 of Cryptosporidium parvum, a new 17-kilodalton antigen.

Authors:  Jeffrey W Priest; James P Kwon; Joel M Montgomery; Caryn Bern; Delynn M Moss; Amanda R Freeman; Cara C Jones; Michael J Arrowood; Kimberly Y Won; Patrick J Lammie; Robert H Gilman; Jan R Mead
Journal:  Clin Vaccine Immunol       Date:  2010-04-21

3.  Serum antibodies from a subset of horses positive for Babesia caballi by competitive enzyme-linked immunosorbent assay demonstrate a protein recognition pattern that is not consistent with infection.

Authors:  Peter O Awinda; Robert H Mealey; Laura B A Williams; Patricia A Conrad; Andrea E Packham; Kathryn E Reif; Juanita F Grause; Angela M Pelzel-McCluskey; Chungwon Chung; Reginaldo G Bastos; Lowell S Kappmeyer; Daniel K Howe; SallyAnne L Ness; Donald P Knowles; Massaro W Ueti
Journal:  Clin Vaccine Immunol       Date:  2013-09-18

4.  Molecular characterization of a new Babesia bovis thrombospondin-related anonymous protein (BbTRAP2).

Authors:  Mohamad Alaa Terkawi; Jadsada Ratthanophart; Akram Salama; Mahmoud AbouLaila; Masahito Asada; Akio Ueno; Hend Alhasan; Azirwan Guswanto; Tatsunori Masatani; Naoaki Yokoyama; Yoshifumi Nishikawa; Xuenan Xuan; Ikuo Igarashi
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

Review 5.  New Molecules in Babesia gibsoni and their application for diagnosis, vaccine development, and drug discovery.

Authors:  Youn-Kyoung Goo; Xuenan Xuan
Journal:  Korean J Parasitol       Date:  2014-08-29       Impact factor: 1.341

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.